A DNA-encoded compound library-based approach for the discovery of novel antibiotics - Dr. O. Verho

Webinar given by Dr. Oscar Verho at the Uppsala Antibiotic Center's seminar series on Friday February 4th. Antibiotics constitute an essential pillar of modern medicine, and they are arguably the most successful class of drugs ever used. However, their effectiveness against infectious diseases is currently being challenged by the emergence of pan-drug resistant bacterial pathogens. This is particularly concerning given the fact that very few new novel-mechanism antibiotics have been discovered in the past four decades, and thus there currently exists a large unmet clinical need for new drugs that can combat these emerging threats. In our proposed project, we will seek to identify structurally novel inhibitors of LepB and LpxH, which are two promising but currently underexplored antibiotic targets. To enable efficient hit discovery, we plan to make use of the DNA-encoded compound library (DECL) technology, which currently constitutes the most efficient and cost-effective method for synthesizing and screening compound libraries. If you are interested in our center's upcoming activities, please check https://uac.uu.se

More informative analyses from antibiotics clinical trials & infections caused by resistant bacteria
▶︎

More informative analyses from antibiotics clinical trials & infections caused by resistant bacteria

Toward the Efficient Discovery of Actionable Chemical Matter from DNA-encoded Libraries
▶︎

Toward the Efficient Discovery of Actionable Chemical Matter from DNA-encoded Libraries

A Structure-based Approach to Drugging RNA with Small Molecules
▶︎

A Structure-based Approach to Drugging RNA with Small Molecules

DNA-Encoded Libraries for the Discovery of Small-Molecule Hits
▶︎

DNA-Encoded Libraries for the Discovery of Small-Molecule Hits

Ancient Human Species We Once Co-Existed With
▶︎

Ancient Human Species We Once Co-Existed With

The market and innovation failure of antibiotics: causes and potential solutions - Enrico Baraldi
▶︎

The market and innovation failure of antibiotics: causes and potential solutions - Enrico Baraldi

But what is quantum computing?  (Grover's Algorithm)
▶︎

But what is quantum computing? (Grover's Algorithm)

AlphaFold - The Most Useful Thing AI Has Ever Done
▶︎

AlphaFold - The Most Useful Thing AI Has Ever Done

'Long COVID is a jaw-dropping lie': Doctor’s bombshell testimony ‘exposes’ mRNA vaccine ‘scandal’
▶︎

'Long COVID is a jaw-dropping lie': Doctor’s bombshell testimony ‘exposes’ mRNA vaccine ‘scandal’

The most important lesson from 83,000 brain scans | Daniel Amen | TEDxOrangeCoast
▶︎

The most important lesson from 83,000 brain scans | Daniel Amen | TEDxOrangeCoast

Bioinformatic Approach for Drug Discovery FKUH
▶︎

Bioinformatic Approach for Drug Discovery FKUH

The visual culture of antimicrobial resistance. Dr. Rachel Irwin
▶︎

The visual culture of antimicrobial resistance. Dr. Rachel Irwin

The INCREDIBLE new way bacteria are defending against viruses
▶︎

The INCREDIBLE new way bacteria are defending against viruses

The Medicine of Frequencies. What did Einstein mean? | Dr. Mitchell Abrams | TEDxTrinityBellwoods
▶︎

The Medicine of Frequencies. What did Einstein mean? | Dr. Mitchell Abrams | TEDxTrinityBellwoods

Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!
▶︎

Billionaire's WARNING: I'm SELLING. The Crash Is Already Here!

Golden Retriever Meets Completely Broken Rescue for the First Time
▶︎

Golden Retriever Meets Completely Broken Rescue for the First Time

Sarah Paine — The war for India (Lecture & interview)
▶︎

Sarah Paine — The war for India (Lecture & interview)

How ASML Makes Chips Faster With Its New $400 Million High NA Machine
▶︎

How ASML Makes Chips Faster With Its New $400 Million High NA Machine

Quantum Consciousness and the Origin of Life
▶︎

Quantum Consciousness and the Origin of Life

Advances in Selective Inhibitors: A Multistage Approach to Targeting Plasmodium vivax for Malaria
▶︎

Advances in Selective Inhibitors: A Multistage Approach to Targeting Plasmodium vivax for Malaria